Cipher Capital’s Gilead Sciences GILD Stock Holding History

Cipher Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,821	Closed	-$236K	–	499
2022 Q2	$236K	Buy	+3,821	New	+$237K	0.05%	328

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cipher Capital's GILD Position: Q3 2022 in Review

Cipher Capital sold out of Gilead Sciences (GILD) in Q3 2022, closing a stake of 3,821 shares — an estimated $236K sold.

Cipher Capital first reported a position in GILD in Q2 2022 and held it in 1 quarter. The position peaked at $236K in Q2 2022. 1,603 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

Cipher Capital reported no remaining Gilead Sciences position as of Q3 2022 after selling out during the quarter.
Cipher Capital sold 3,821 Gilead Sciences shares in Q3 2022, an estimated $236K.
Cipher Capital first reported a position in Gilead Sciences in Q2 2022 and held it in 1 quarter.
Cipher Capital's Gilead Sciences position peaked at $236K in Q2 2022.
1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on Cipher Capital's 13F filing for Q3 2022, filed 14 Nov 2022.